Avita said it now sees full year commercial revenue of about $49.5M to $50.5M, compared to a previous forecast of $51M to $53M.The revision to the guidance comes to due the result of slower-than ...
AVITA Medical, Inc., through its subsidiaries, engages in the development and commercialization of a technology platform that enables point-of-care autologous skin restoration for multiple unmet ...
Avita Corp. is a manufacturer of healthcare products, such as blood pressure monitors, electronic lice combs, nasal aspirators and thermometers. The company was founded in 1996 and is ...
VALENCIA, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care ...
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Avita Medical (RCEL – Research Report) and ...
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite surging more than 250 points on Thursday. The Dow traded up 0.18% to 38,532.50 while the NASDAQ rose 1.63% to 16,433. ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
VALENCIA, Calif., April 15, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
BTIG downgraded Avita Medical (NASDAQ:RCEL) to neutral, citing the company’s lowered Q1 2024 guidance. “Overall, while we are still confident in the RECELL technology, we are not confident in ...
He will have "700 broiler meat chickens that I’ll raise out on pasture and a few laying hens, as well as around 65 ...